NEW ORLEANS -- More extensive N1 lymph node assessment may better guide therapy after non-small cell lung cancer (NSCLC) resections with curative intent, real-world data suggested. The more N1 ...

Invasion Factors uPA/PAI-1 and HER2 Status Provide Independent and Complementary Information on Patient Outcome in Node-Negative Breast Cancer Purpose: We postulate that surgical sampling and ...

NEW ORLEANS — January 31, 2026 — Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for ...

Evaluation of the hilar and mediastinal lymph nodes is part of the surgical treatment of non-small cell lung cancer (NSCLC). It is also vital to the staging of lung cancer, which determines the need ...

Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.

SAN ANTONIO -- Thoracic surgeons were fired up about minimum expectations for surgical lymph node assessment in conjunction with lung cancer resection during a debate at the Society of Thoracic ...

Stage 3 non-small cell lung cancer has spread to nearby tissues and lymph nodes but not to more distant tissues. Most people with this stage have lung cancer symptoms. Treatment can depend on several ...